Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion

被引:5
|
作者
Goulart Fernandes Dias, Paulo Henrique [1 ]
Oliveira, Gabriel Augusto [2 ]
Fernandes Dias, Fernando Goulart [3 ]
Xavier Gomes, Regina de Paula [4 ,5 ]
Tambara Filho, Renato [6 ]
de Fraga, Rogerio [6 ]
机构
[1] Fed Univ Parana UFPR, Postgrad Program Clin Surg, Curitiba, PR, Brazil
[2] UFPR, Sch Med, Curitiba, PR, Brazil
[3] Univ Estadual Campinas, UNICAMP, Dept Urol, Campinas, SP, Brazil
[4] PUCPR, Div Pathol, Curitiba, PR, Brazil
[5] UFPR, Div Pathol, Curitiba, Parana, Brazil
[6] UFPR, Dept Surg, Div Urol, Curitiba, PR, Brazil
关键词
Immunosuppression; Tacrolimus; Ischemia; Reperfusion; Histology; Kidney; Rats; CYCLOSPORINE; SIROLIMUS;
D O I
10.1590/S0102-86502015002000007
中图分类号
R61 [外科手术学];
学科分类号
摘要
PURPOSE: To evaluate renal histological changes and renal function in single kidney rats submitted to renal ischemia-reperfusion and to immunosuppression with tacrolimus and mycophenolate-mofetil. METHODS: Experimental study with 80 Wistar rats distributed into control, Sham and six other groups treated with immunosuppressive drugs. Animals undergoing surgery, right nephrectomy and left renal clamping, killed on the 14th day and analyzed for renal histology, urea and creatinine. RESULTS: The group receiving tacrolimus at higher doses (T3) showed renal histological lesions indicative of early nephrotoxicity, and significant increase in urea and creatinine. The group M (mycophenolate-mofetil alone) and the group M2 (mycophenolate-mofetil combined with half the usual dose of tacrolimus) presented a slight rise in serum urea. The groups using mycophenolate-mofetil alone or combined with tacrolimus showed creatinine levels similar to that of the group T3. CONCLUSIONS: Histologically, the association of injury by ischemia-reperfusion with the use of tacrolimus or mycophenolatemofetil alone demonstrated a higher rate of renal changes typical of early nephrotoxicity. In laboratory, the combination of injury by ischemia-reperfusion with tacrolimus at higher doses proved to be nephrotoxic.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 50 条
  • [21] Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin
    Schulz, T
    Martin, D
    Helmes, M
    Klempnauer, J
    Buesing, M
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1533 - 1535
  • [22] A Novel Formula to Determine Optimal Immunosuppression in Renal Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: Towards Individualized Immunosuppression
    Pankewycz, O.
    Laftavi, M.
    Onan, E.
    Rucker, D.
    Wang, D.
    Bhuta, K.
    Gruessner, R.
    Gruessner, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 668 - 669
  • [23] Pediatric renal transplantation with mycophenolate mofetil immunosuppression in a single center from Mexico
    Martinez-Mier, Gustavo
    Mendez-Lopez, Marco T.
    Budar-Fernandez, Luis F.
    Estrada-Oros, Jorge
    Franco-Abaroa, Regino
    George-Micelli, Esteban
    Rios-Martinez, Luis
    Calzada-Grijalva, Jose Francisco
    Gonzalez-Velazquez, Felipe
    PEDIATRIC TRANSPLANTATION, 2007, 11 (02) : 134 - 138
  • [24] Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
    Ciancio, G
    Miller, A
    Burke, GW
    Gharagozloo, H
    Rosen, A
    Roth, D
    Kupin, W
    Pinna, A
    Cespedes, M
    Esquenazi, V
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1013 - 1014
  • [25] Corticosteroid minimization in pediatric renal transplant recipients under thymoglobulin, tacrolimus and mycophenolate mofetil immunosuppression.
    Smith, LD
    Somerville, KT
    Holman, J
    Sherbotie, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 647A - 647A
  • [26] Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression
    Grewal, HP
    Thistlethwaite, JR
    Loss, GE
    Bruce, DS
    Siegel, CT
    Cronin, DC
    Newell, KA
    Millis, JM
    Woodle, ES
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1378 - 1379
  • [27] Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function
    Liu, B
    Lin, ZB
    Ming, CS
    Zhang, WJ
    Chen, ZS
    Sha, B
    Zeng, FJ
    Chen, S
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 87 - 88
  • [28] MYCOPHENOLATE MOFETIL REDUCED RENAL INFLAMMATION AND PROTECTED RENAL CORTICAL OXYGENATION AFTER ISCHEMIA/REPERFUSION INJURY
    Bezemer, R.
    Ergin, B.
    Kandil, A.
    Almac, E.
    Demirci, C.
    Ince, C.
    INTENSIVE CARE MEDICINE, 2012, 38 : S209 - S209
  • [29] MICROVESICLES ABROGATE THE EFFECTS OF RENAL ISCHEMIA REPERFUSION INJURY ON KIDNEY FUNCTION
    Whalen, H.
    Clancy, M.
    Shiels, P.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 10 - 11
  • [30] Excellent outcome of ABO-incompatible kidney transplantation under pretransplant immunosuppression with tacrolimus, mycophenolate mofetil, and steroid
    Tanabe, K
    Tokumoto, T
    Ishida, H
    Ishikawa, N
    Miyamoto, N
    Kondo, S
    Shimmura, H
    Setoguchi, K
    Toma, H
    JOURNAL OF UROLOGY, 2004, 171 (04): : 514 - 514